Global Self-Monitoring Blood Glucose System Market By Type (Blood Glucose meters, Testing strips, and Lancets & Lancing Devices), By Application (Type 2 Diabetes, Type 1 Diabetes, and Gestational Diabetes), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019-2028
- account_circleAbout Me
keyboard_arrow_up
Quick Navigation
The report on Self-Monitoring Blood Glucose System Market offers in-depth analysis of market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global self-monitoring blood glucose system market is segmented on the basis of type, application, and geography.
The Worldwide market for Self-Monitoring Blood Glucose System Market is expected to grow at a CAGR of roughly x.x% over the next nine years, and will reach US$ XX.X Mn in 2028, from US$ XX.X Mn in 2018, according to a new Market.us (Prudour Research) study.
Self-Monitoring Blood Glucose System Market Scope:
By type, the market is segmented into Blood Glucose meters, Testing strips, and Lancets & Lancing Devices. By application, the market is divided into Type 2 Diabetes, Type 1 Diabetes, and Gestational Diabetes.
Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Roche (Switzerland), Abbott (US), LifeScan (US), Ascensia (Switzerland), Medtronic (Ireland) Dexcom (US), Ypsomed (Switzerland), Ypsomed (Switzerland), Nipro (Japan) Sanofi (France), ARKRAY (Japan), Prodigy Diabetes Care (US), ACON Laboratories (US), and Nova Biomedical (US).
Key Market Segments
Type
- Blood Glucose meters
- Testing strips
- Lancets & Lancing Devices
Application
- Type 2 Diabetes
- Type 1 Diabetes
- Gestational Diabetes
Key Market Players included in the report:
- Roche (Switzerland)
- Abbott (US)
- LifeScan (US)
- Ascensia (Switzerland)
- Medtronic (Ireland) Dexcom (US)
- Ypsomed (Switzerland)
- Ypsomed (Switzerland)
- Nipro (Japan) Sanofi (France)
- ARKRAY (Japan)
- Prodigy Diabetes Care (US)
- ACON Laboratories (US)
- Nova Biomedical (US)
Reasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Self-Monitoring Blood Glucose System Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Self-Monitoring Blood Glucose System Market; high-growth regions; and market drivers, restraints, and also market chances.
The analysis covers Self-Monitoring Blood Glucose System Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Self-Monitoring Blood Glucose System Market across sections such as also application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Self-Monitoring Blood Glucose System Market together side their company profiles, SWOT analysis, latest advancements, and business plans.
The analysis objectives of the report are:
- To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
- To know the Self-Monitoring Blood Glucose System Market by pinpointing its many subsegments.
- To profile the important players and analyze their growth plans.
- To endeavor the amount and value of Self-Monitoring Blood Glucose System sub-markets, depending on key regions (various vital states).
- To analyze Self-Monitoring Blood Glucose System Market concerning growth trends, prospects, and also their participation in the entire sector.
- To examine and study the Self-Monitoring Blood Glucose System Market size (volume & value) from the company, essential regions/countries, products, and application, background information from 2014 to 2019, and also prediction to 2028.
- Primary worldwide Self-Monitoring Blood Glucose System Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
- To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.
For the Self-Monitoring Blood Glucose System Market research study, the following years have been considered to estimate the market size:
Attribute Report Details Historical Years
2016-2020
Base Year
2021
Estimated Year
2022
Short Term Projection Year
2028
Projected Year
2023
Long Term Projection Year
2032
Report Coverage
Competitive Landscape, Revenue analysis, Company Share Analysis, Manufacturers Analysis, Volume by Manufacturers, Key Segments, Key company analysis, Market Trends, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis, strategy for existing players to grab maximum market share, and more.
Regional Scope
North America, Europe, Asia-Pacific, South America, Middle East & Africa
Country Scope
United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa
- account_circleAbout Me
- 1. Self-Monitoring Blood Glucose System Market Introduction
- 1.1. Definition
- 1.2. Taxonomy
- 1.3. Research Scope
- 2. Executive Summary
- 2.1. Key Findings by Major Segments
- 2.2. Top strategies by Major Players
- 3. Global Self-Monitoring Blood Glucose System Market Overview
- 3.1. Self-Monitoring Blood Glucose System Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Opportunities
- 3.1.3. Restraints
- 3.1.4. Challenges
- 3.2. PESTLE Analysis
- 3.3. Opportunity Map Analysis
- 3.4. PORTER'S Five Forces Analysis
- 3.5. Market Competition Scenario Analysis
- 3.6. Product Life Cycle Analysis
- 3.7. Opportunity Orbits
- 3.8. Production Analysis by Region/Company
- 3.9. Industry chain Analysis
- 3.10. Marketing Strategy
- 3.1. Self-Monitoring Blood Glucose System Market Dynamics
- 4. Global Self-Monitoring Blood Glucose System Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
- 4.1. Global Self-Monitoring Blood Glucose System Market Analysis by Type: Introduction
- 4.2. Market Size and Forecast by Region
- 4.3. Blood Glucose meters
- 4.4. Testing strips
- 4.5. Lancets & Lancing Devices
- 5. Global Self-Monitoring Blood Glucose System Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
- 5.1. Global Self-Monitoring Blood Glucose System Market Analysis by Application: Introduction
- 5.2. Market Size and Forecast by Region
- 5.3. Type 2 Diabetes
- 5.4. Type 1 Diabetes
- 5.5. Gestational Diabetes
- 6. Global Self-Monitoring Blood Glucose System Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
- 6.1. North America
- 6.1.1. North America Self-Monitoring Blood Glucose System Market: Regional Trend Analysis
- 6.1.1.1. US
- 6.1.1.2. Canada
- 6.1.1.3. Mexico
- 6.1.1. North America Self-Monitoring Blood Glucose System Market: Regional Trend Analysis
- 6.2.1. Europe
- 6.2.1. Europe Self-Monitoring Blood Glucose System Market: Regional Trend Analysis
- 6.2.1.1. Germany
- 6.2.1.2. France
- 6.2.1.3. UK
- 6.2.1.4. Russia
- 6.2.1.5. Italy
- 6.2.1.6. Spain
- 6.2.1.7. Rest of Europe
- 6.2.1. Europe Self-Monitoring Blood Glucose System Market: Regional Trend Analysis
- 6.3. Asia-Pacific
- 6.3.1. Asia-Pacific Self-Monitoring Blood Glucose System Market: Regional Trend Analysis
- 6.3.1.1. China
- 6.3.1.2. Japan
- 6.3.1.3. Korea
- 6.3.1.4. India
- 6.3.1.5. Rest of Asia-Pacific
- 6.3.1. Asia-Pacific Self-Monitoring Blood Glucose System Market: Regional Trend Analysis
- 6.4. Latin America
- 6.4.1. Latin America Self-Monitoring Blood Glucose System Market: Regional Trend Analysis
- 6.4.1.1. Brazil
- 6.4.1.2. Argentina
- 6.4.1.3. Rest of Latin America
- 6.4.1. Latin America Self-Monitoring Blood Glucose System Market: Regional Trend Analysis
- 6.5. Middle East and Africa
- 6.5.1. Middle East and Africa Self-Monitoring Blood Glucose System Market: Regional Trend Analysis
- 6.5.1.1. GCC
- 6.5.1.2. South Africa
- 6.5.1.3. Israel
- 6.5.1.4. Rest of MEA
- 6.5.1. Middle East and Africa Self-Monitoring Blood Glucose System Market: Regional Trend Analysis
- 6.1. North America
- 7. Global Self-Monitoring Blood Glucose System Market Competitive Landscape, Market Share Analysis, and Company Profiles
- 7.1. Market Share Analysis
- 7.2. Company Profiles
- 7.3. Roche (Switzerland)
- 7.3.1. Company Overview
- 7.3.2. Financial Highlights
- 7.3.3. Product Portfolio
- 7.3.4. SWOT Analysis
- 7.3.5. Key Strategies and Developments
- 7.4. Abbott (US)
- 7.4.1. Company Overview
- 7.4.2. Financial Highlights
- 7.4.3. Product Portfolio
- 7.4.4. SWOT Analysis
- 7.4.5. Key Strategies and Developments
- 7.5. LifeScan (US)
- 7.5.1. Company Overview
- 7.5.2. Financial Highlights
- 7.5.3. Product Portfolio
- 7.5.4. SWOT Analysis
- 7.5.5. Key Strategies and Developments
- 7.6. Ascensia (Switzerland)
- 7.6.1. Company Overview
- 7.6.2. Financial Highlights
- 7.6.3. Product Portfolio
- 7.6.4. SWOT Analysis
- 7.6.5. Key Strategies and Developments
- 7.7. Medtronic (Ireland) Dexcom (US)
- 7.7.1. Company Overview
- 7.7.2. Financial Highlights
- 7.7.3. Product Portfolio
- 7.7.4. SWOT Analysis
- 7.7.5. Key Strategies and Developments
- 7.8. Ypsomed (Switzerland)
- 7.8.1. Company Overview
- 7.8.2. Financial Highlights
- 7.8.3. Product Portfolio
- 7.8.4. SWOT Analysis
- 7.8.5. Key Strategies and Developments
- 7.9. Ypsomed (Switzerland)
- 7.9.1. Company Overview
- 7.9.2. Financial Highlights
- 7.9.3. Product Portfolio
- 7.9.4. SWOT Analysis
- 7.9.5. Key Strategies and Developments
- 7.10. Nipro (Japan) Sanofi (France)
- 7.10.1. Company Overview
- 7.10.2. Financial Highlights
- 7.10.3. Product Portfolio
- 7.10.4. SWOT Analysis
- 7.10.5. Key Strategies and Developments
- 7.11. ARKRAY (Japan)
- 7.11.1. Company Overview
- 7.11.2. Financial Highlights
- 7.11.3. Product Portfolio
- 7.11.4. SWOT Analysis
- 7.11.5. Key Strategies and Developments
- 7.12. Prodigy Diabetes Care (US)
- 7.12.1. Company Overview
- 7.12.2. Financial Highlights
- 7.12.3. Product Portfolio
- 7.12.4. SWOT Analysis
- 7.12.5. Key Strategies and Developments
- 7.13. ACON Laboratories (US)
- 7.13.1. Company Overview
- 7.13.2. Financial Highlights
- 7.13.3. Product Portfolio
- 7.13.4. SWOT Analysis
- 7.13.5. Key Strategies and Developments
- 7.14. Nova Biomedical (US)
- 7.14.1. Company Overview
- 7.14.2. Financial Highlights
- 7.14.3. Product Portfolio
- 7.14.4. SWOT Analysis
- 7.14.5. Key Strategies and Developments
- 8. Assumptions and Acronyms
- 9. Research Methodology
- 10. Contact
- 1. Self-Monitoring Blood Glucose System Market Introduction
- ondemand_videoVideos
- Roche (Switzerland)
- Abbott (US)
- LifeScan (US)
- Ascensia (Switzerland)
- Medtronic (Ireland) Dexcom (US)
- Ypsomed (Switzerland)
- Nipro (Japan) Sanofi (France)
- ARKRAY (Japan)
- Prodigy Diabetes Care (US)
- ACON Laboratories (US)
- Nova Biomedical (US)
- settingsSettings
Our Clients
- 35413
- Aug 2022
-
US $5,999US $4,499
-
US $7,999US $4,999
-
US $9,999US $5,499
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$5,999
$4,499
USD / per unit
save 25%
|
Multi User
$7,999
$4,999
USD / per unit
save 38%
|
Corporate User
$9,999
$5,499
USD / per unit
save 45%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
